22nd Century Group
在场
高管
查看带有其 15 名主要高管的组织结构图
22nd Century Group 搜索最多的简介
高管在22nd Century Group变化
- Calvin TreatCalvin Treat 将于20225月23作为 Chief Scientific Officer 加入公司 (新闻发布的2022四月12号).
- John Franzino已作为Chief Administrative Officer加入公司 (新闻发布的2022一月21号).
- James Mish 曾任 Chief Executive Officer, 现任 Chief Executive Officer and Director (新闻发布的2022一月21号).
创建提醒
跟踪 22nd Century Group 的高管变动
生物技术
22nd Century Group 拥有 2,010 家竞争者，其中包括 Neptune Wellness Solutions (加拿大)、Inivata (美国(美洲)) 和 Adma Biologics (美国(美洲))。
Popular M&A news in 生物技术
- Innoviva has announced the acquisition of Entasis Therapeutics (公布2022五月24号).
- Remix Therapeutics 刚刚宣布为 70 筹款数百万美元。 (公布2022五月19号).
- Kriya Therapeutics 刚刚宣布为 270 筹款数百万美元。 (公布2022五月19号).
生物技术 行业的其他推荐联系人
消息
22nd Century Group 的最新新闻稿
- 22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings
- 22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business
- 22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
- 22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
- 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022
- 22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA’s Proposed Ban on Menthol Cigarettes
- 22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders
- 22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference
- 22nd Century to Participate in September and October 2021 Investor Conferences :: 22nd Century Group, Inc. (XXII)
- 22nd Century Group Enters Global Specialty Hops Market :: 22nd Century Group, Inc. (XXII)
- View more press releases Close
通过电子邮件
